Professor John Myburgh
Professor John Myburgh MBBCh, PhD, FCICM.
Director of Division of Critical Care and Trauma, The George Institute for Global Health; Professor of Critical Care, University of New South Wales.Professor Myburgh is a senior physician in the Department of Intensive Care Medicine at St George Hospital, Sydney. He also holds honorary professorial appointments at Universities of Sydney and Monash University.
Professor Myburgh graduated in Medicine from the University of Witwatersrand in 1981. In 2002, he completed his PhD through the University of Adelaide. He has been actively involved in intensive care research for the last 20 years. He was a foundation member and past Chair of the Australian and New Zealand Intensive Care Society Clinical Trials Group and has received over $36M in competitive research funding since 2000. He has conducted 10 randomised-controlled trials, recruiting over 19000 patients in the last 15 years. He has published over 120 original articles, including 4 papers in the New England Journal of Medicine and 20 book chapters.
His research interests include catecholamine pharmacodynamics, traumatic brain injury, fluid resuscitation, endocrine homeostasis and thermoregulation in critical illness.
He was a chief investigator on the Saline vs Albumin Fluid Evaluation (SAFE) study and the SAFE-TBI study, the Normoglycaemia in Intensive Care Evaluation (NICE) and the Randomised Evaluation of Normal vs Augmented Level renal replacement therapy (RENAL) studies. He is currently leading the Crystalloid vs Hydroxyethyl starch Trial (CHEST) and the Evaluation in Sepsis of Corticosteroids and Placebo Trial (ESCAPE).
In addition to his research activities, he has a long-standing involvement in education and is the current President of the College of Intensive Care Medicine of Australia and New Zealand.
